DAMORA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$21.49
-2.36%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+6.2%
3 months
-24.8%
6 months
-15.3%
1 year
+192.4%
Year to date
-6.6%
52-week range
$4.95 – $34.14
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.33B
P/E
-5
P/B
2.6
P/S
—
Revenue
$0
Net income
-$262.83M
Diluted EPS
7.49
Gross margin
—
Net margin
—
Return on equity
-82.40%
Total debt
$0
Cash
$540.52M
Free cash flow
-$44.52M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$31.17M | — | — | -$21.87M |
| Mar 31, 2026 | $0 | -$27.78M | — | — | -$20.6M |
| Dec 31, 2025 | $0 | -$200.74M | — | — | $566K |
| Sep 30, 2025 | $0 | -$3.13M | — | — | -$2.62M |
| Jun 30, 2025 | $0 | -$3.44M | — | — | -$2.24M |
| Mar 31, 2025 | $0 | -$2.53M | — | — | -$2.44M |
| Dec 31, 2024 | $0 | -$6.74M | — | — | -$4.94M |
| Sep 30, 2024 | $0 | -$3.88M | — | — | -$3.65M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent DMRA news
All market newsNo ticker-linked stories are in the current archive.